TABLE 3.
Features of IC Compared With Non-IC Subjects in 302 Patients With Crypto at UAB, 1996–2010
| Characteristic | IC N = 263 (%) | Non-IC N = 39 (%) | P Value |
|---|---|---|---|
| Mean age, years (SD) | 50 (14.8) | 49 (14.9 | 0.815 |
| Male gender | 177 (67) | 26 (67) | 0.962 |
| Caucasian | 141 (54) | 31 (79) | 0.002 |
| Underlying IC disease | |||
| HIV | 108 (41) | n/a | n/a |
| OTRs | 84 (32) | n/a | n/a |
| Cancer | 31 (12) | n/a | n/a |
| Chronic steroids | 27 (10) | n/a | n/a |
| Diabetes mellitus | 13 (5) | n/a | n/a |
| CKD / ESRD | 7 (3) | n/a | n/a |
| Cirrhosis | 5 (2) | n/a | n/a |
Abbreviations: IC, immunocompromised; HIV, human immunodeficiency virus; OTRs, organ transplant recipients; CKD, chronic kidney disease; ESRD, end-stage renal disease; n/a, not available.